Literature DB >> 9717962

Inducible nitric oxide synthase in human diseases.

K D Kröncke1, K Fehsel, V Kolb-Bachofen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9717962      PMCID： PMC1905037          DOI： 10.1046/j.1365-2249.1998.00648.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  126 in total

1.  Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis.

Authors:  C C Yang; R B Alvarez; W K Engel; V Askanas
Journal:  Neuroreport       Date:  1996-12-20       Impact factor: 1.837

2.  Expression of human inducible nitric oxide synthase is regulated by both promoter and 3'-regions.

Authors:  Y Nunokawa; S Oikawa; S Tanaka
Journal:  Biochem Biophys Res Commun       Date:  1997-04-17       Impact factor: 3.575

3.  Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses.

Authors:  S C Watkins; W Macaulay; D Turner; R Kang; H E Rubash; C H Evans
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

4.  Nitric oxide synthase is expressed in human macrophages during foreign body inflammation.

Authors:  E Moilanen; T Moilanen; R Knowles; I Charles; Y Kadoya; N al-Saffar; P A Revell; S Moncada
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

Review 5.  Bright and dark sides of nitric oxide in ischemic brain injury.

Authors:  C Iadecola
Journal:  Trends Neurosci       Date:  1997-03       Impact factor: 13.837

6.  Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  D Saleh; P J Barnes; A Giaid
Journal:  Am J Respir Crit Care Med       Date:  1997-05       Impact factor: 21.405

7.  Role of nitric oxide in Sjögren's syndrome.

Authors:  Y T Konttinen; L A Platts; S Tuominen; K K Eklund; N Santavirta; J Törnwall; T Sorsa; M Hukkanen; J M Polak
Journal:  Arthritis Rheum       Date:  1997-05

8.  Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis.

Authors:  D C Hooper; O Bagasra; J C Marini; A Zborek; S T Ohnishi; R Kean; J M Champion; A B Sarker; L Bobroski; J L Farber; T Akaike; H Maeda; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

9.  Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells.

Authors:  K Yoshioka; J Thompson; M J Miller; J W Fisher
Journal:  Biochem Biophys Res Commun       Date:  1997-03-27       Impact factor: 3.575

10.  Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.

Authors:  M Satoh; M Nakamura; G Tamura; S Makita; I Segawa; A Tashiro; R Satodate; K Hiramori
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094
View more
  118 in total

1.  Dimerization of major histocompatibility complex class I on the surface of THP-1 cells stimulates the expression of inducible nitric oxide synthase and subsequent nitric oxide release.

Authors:  G Bottley; N Fernández
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

2.  Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells.

Authors:  R Friedl; T Moeslinger; B Kopp; P G Spieckermann
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  On the activation of soluble guanylyl cyclase by nitric oxide.

Authors:  Tomas C Bellamy; John Wood; John Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  Zinc finger transcription factors as molecular targets for nitric oxide-mediated immunosuppression: inhibition of IL-2 gene expression in murine lymphocytes.

Authors:  D Berendji; V Kolb-Bachofen; P F Zipfel; C Skerka; C Carlberg; K D Kröncke
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

5.  Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formation.

Authors:  Stephanie Schwalm; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

6.  Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species.

Authors:  Fernanda O Novais; Ba T Nguyen; Daniel P Beiting; Lucas P Carvalho; Nelson D Glennie; Sara Passos; Edgar M Carvalho; Phillip Scott
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

7.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

8.  Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells.

Authors:  Y Choi; M K Lee; S Y Lim; S H Sung; Y C Kim
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

9.  Interleukin-1β reduces L-type Ca2+ current through protein kinase Cϵ activation in mouse heart.

Authors:  Nabil El Khoury; Sophie Mathieu; Céline Fiset
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

10.  17β-Estradiol attenuates cytokine-induced nitric oxide production in rat hepatocyte.

Authors:  Ikenna C Nweze; Jason W Smith; Baochun Zhang; Carolyn M Klinge; Jaganathan Lakshmanan; Brian G Harbrecht
Journal:  J Trauma Acute Care Surg       Date:  2012-08       Impact factor: 3.313
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.